Nektar Therapeutics Stock-Based Compensation
Nektar Therapeutics (NKTR) reported Stock-Based Compensation of $3.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- Nektar Therapeutics share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.37M, a 3.47% decline year-over-year.
- Nektar Therapeutics share-based payment arrangement, expense for the quarter ending 2026-03-31 was $3.35M, a 13.93% decline year-over-year.
- Nektar Therapeutics share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.19M, a 54.34% decline year-over-year.
- Nektar Therapeutics share-based payment arrangement, expense for the quarter ending 2025-09-30 was $3.07M, a 43.02% decline year-over-year.
- Nektar Therapeutics share-based payment arrangement, expense for fiscal 2025 was $12.65M, a 41.47% decline from fiscal 2024.
- Nektar Therapeutics share-based payment arrangement, expense for fiscal 2024 was $21.61M, a 35.27% decline from fiscal 2023.
- Nektar Therapeutics share-based payment arrangement, expense for fiscal 2023 was $33.39M, a 41.75% decline from fiscal 2022.
- Nektar Therapeutics share-based payment arrangement, expense for fiscal 2022 was $57.32M, a 39.46% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.37M 10-Q · filed 2026-08-14 | $6.72M 10-Q · filed 2026-08-14 | $8.91M derived: sum of 3 quarters · filed 2026-08-14 | $11.98M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-05-08 | $5.55M derived: sum of 2 quarters · filed 2026-05-08 | $8.62M derived: sum of 3 quarters · filed 2026-05-08 | $12.11M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $5.26M derived: sum of 2 quarters · filed 2026-03-13 | $8.75M derived: sum of 3 quarters · filed 2026-08-14 | $12.65M 10-K · filed 2026-03-13 | |
| 2025-09-30 | $3.07M 10-Q · filed 2025-11-07 | $6.56M derived: sum of 2 quarters · filed 2026-08-14 | $10.46M 10-Q · filed 2025-11-07 | $15.26M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $3.49M 10-Q · filed 2026-08-14 | $7.38M 10-Q · filed 2026-08-14 | $12.19M derived: sum of 3 quarters · filed 2026-08-14 | $17.58M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $3.90M 10-Q · filed 2026-05-08 | $8.70M derived: sum of 2 quarters · filed 2026-05-08 | $14.09M derived: sum of 3 quarters · filed 2026-05-08 | $19.51M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $10.19M derived: sum of 2 quarters · filed 2026-03-13 | $15.61M derived: sum of 3 quarters · filed 2026-03-13 | $21.61M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $5.39M 10-Q · filed 2025-11-07 | $10.81M derived: sum of 2 quarters · filed 2025-11-07 | $16.81M 10-Q · filed 2025-11-07 | $24.06M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $5.42M 10-Q · filed 2025-08-08 | $11.42M 10-Q · filed 2025-08-08 | $18.67M derived: sum of 3 quarters · filed 2025-08-08 | $26.82M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $6.00M 10-Q · filed 2025-05-09 | $13.25M derived: sum of 2 quarters · filed 2025-05-09 | $21.40M derived: sum of 3 quarters · filed 2025-05-09 | $29.37M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $15.40M derived: sum of 2 quarters · filed 2025-03-14 | $23.37M derived: sum of 3 quarters · filed 2025-03-14 | $33.39M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $8.15M 10-Q · filed 2024-11-08 | $16.11M derived: sum of 2 quarters · filed 2024-11-08 | $26.13M 10-Q · filed 2024-11-08 | $38.87M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $7.97M 10-Q · filed 2024-08-09 | $17.98M 10-Q · filed 2024-08-09 | $30.72M derived: sum of 3 quarters · filed 2024-08-09 | $43.24M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $10.02M 10-Q · filed 2024-05-10 | $22.76M derived: sum of 2 quarters · filed 2024-05-10 | $35.27M derived: sum of 3 quarters · filed 2024-05-10 | $46.38M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $12.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $25.26M derived: sum of 2 quarters · filed 2024-03-05 | $36.36M derived: sum of 3 quarters · filed 2024-03-05 | $57.32M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $12.52M 10-Q · filed 2023-11-08 | $23.62M derived: sum of 2 quarters · filed 2023-11-08 | $44.58M 10-Q · filed 2023-11-08 | $66.99M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $11.10M 10-Q · filed 2023-08-09 | $32.06M 10-Q · filed 2023-08-09 | $54.47M derived: sum of 3 quarters · filed 2024-03-05 | $79.13M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $20.96M 10-Q · filed 2023-05-10 | $43.37M derived: sum of 2 quarters · filed 2024-03-05 | $68.02M derived: sum of 3 quarters · filed 2024-03-05 | $91.74M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | $22.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $47.06M derived: sum of 2 quarters · filed 2024-03-05 | $70.78M derived: sum of 3 quarters · filed 2024-03-05 | $94.67M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $24.66M 10-Q · filed 2022-11-04 | $48.37M derived: sum of 2 quarters · filed 2022-11-04 | $72.27M 10-Q · filed 2022-11-04 | $94.26M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $23.71M 10-Q · filed 2022-08-05 | $47.61M 10-Q · filed 2022-08-05 | $69.60M derived: sum of 3 quarters · filed 2023-02-28 | $93.27M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $23.90M 10-Q · filed 2022-05-06 | $45.88M derived: sum of 2 quarters · filed 2023-02-28 | $69.55M derived: sum of 3 quarters · filed 2023-02-28 | $92.92M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $21.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $45.65M derived: sum of 2 quarters · filed 2023-02-28 | $69.03M derived: sum of 3 quarters · filed 2023-02-28 | $94.26M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $23.67M 10-Q · filed 2021-11-05 | $47.04M derived: sum of 2 quarters · filed 2021-11-05 | $72.27M 10-Q · filed 2021-11-05 | $97.28M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $23.37M 10-Q · filed 2021-08-06 | $48.61M 10-Q · filed 2021-08-06 | $73.61M derived: sum of 3 quarters · filed 2022-03-01 | $98.50M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $25.24M 10-Q · filed 2021-05-07 | $50.24M derived: sum of 2 quarters · filed 2022-03-01 | $75.12M derived: sum of 3 quarters · filed 2022-03-01 | $99.65M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $25.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $49.89M derived: sum of 2 quarters · filed 2022-03-01 | $74.41M derived: sum of 3 quarters · filed 2022-03-01 | $99.80M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $24.88M 10-Q · filed 2020-11-06 | $49.40M derived: sum of 2 quarters · filed 2020-11-06 | $74.79M 10-Q · filed 2020-11-06 | $98.99M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $24.52M 10-Q · filed 2020-08-07 | $49.91M 10-Q · filed 2020-08-07 | $74.11M derived: sum of 3 quarters · filed 2021-02-26 | $97.40M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $25.39M 10-Q · filed 2020-05-08 | $49.59M derived: sum of 2 quarters · filed 2021-02-26 | $72.88M derived: sum of 3 quarters · filed 2021-02-26 | $93.54M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $24.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $47.49M derived: sum of 2 quarters · filed 2021-02-26 | $68.15M derived: sum of 3 quarters · filed 2021-02-26 | $88.10M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $23.29M 10-Q · filed 2019-11-07 | $43.95M derived: sum of 2 quarters · filed 2019-11-07 | $63.90M 10-Q · filed 2019-11-07 | $75.39M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-06-30 | $20.66M 10-Q · filed 2019-08-09 | $20.66M 10-Q · filed 2018-08-09 | $40.61M 10-Q · filed 2019-08-09 | $52.10M derived: sum of 3 quarters · filed 2020-02-28 | $60.94M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $19.95M 10-Q · filed 2019-05-09 | $31.45M derived: sum of 2 quarters · filed 2020-02-28 | $40.28M derived: sum of 3 quarters · filed 2020-02-28 | $48.38M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2017-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $20.33M derived: sum of 2 quarters · filed 2020-02-28 | $28.43M derived: sum of 3 quarters · filed 2020-02-28 | $36.62M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $8.84M 10-Q · filed 2018-11-08 | $16.93M derived: sum of 2 quarters · filed 2018-11-08 | $25.12M 10-Q · filed 2018-11-08 | $32.17M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $8.10M 10-Q · filed 2018-08-09 | $16.28M 10-Q · filed 2018-08-09 | $23.34M derived: sum of 3 quarters · filed 2019-03-01 | $29.51M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $8.18M 10-Q · filed 2018-05-10 | $15.24M derived: sum of 2 quarters · filed 2019-03-01 | $21.41M derived: sum of 3 quarters · filed 2019-03-01 | $27.67M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $13.22M derived: sum of 2 quarters · filed 2019-03-01 | $19.49M derived: sum of 3 quarters · filed 2019-03-01 | $25.85M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $6.17M 10-Q · filed 2017-11-08 | $12.43M derived: sum of 2 quarters · filed 2017-11-08 | $18.79M 10-Q · filed 2017-11-08 | $23.96M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | $6.26M 10-Q · filed 2017-08-09 | $12.63M 10-Q · filed 2017-08-09 | $17.80M derived: sum of 3 quarters · filed 2018-03-01 | $22.56M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $6.36M 10-Q · filed 2017-05-10 | $11.53M derived: sum of 2 quarters · filed 2018-03-01 | $16.30M derived: sum of 3 quarters · filed 2018-03-01 | $20.86M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $9.93M derived: sum of 2 quarters · filed 2018-03-01 | $14.49M derived: sum of 3 quarters · filed 2018-03-01 | $19.67M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $4.76M 10-Q · filed 2016-11-04 | $9.32M derived: sum of 2 quarters · filed 2016-11-04 | $14.50M 10-Q · filed 2016-11-04 | $18.87M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $4.56M 10-Q · filed 2016-08-04 | $9.74M 10-Q · filed 2016-08-04 | $14.11M derived: sum of 3 quarters · filed 2017-03-01 | $18.23M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $5.18M 10-Q · filed 2016-05-04 | $9.55M derived: sum of 2 quarters · filed 2017-03-01 | $13.67M derived: sum of 3 quarters · filed 2017-03-01 | $17.83M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $8.49M derived: sum of 2 quarters · filed 2017-03-01 | $12.66M derived: sum of 3 quarters · filed 2017-03-01 | $17.02M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $4.12M 10-Q · filed 2015-11-06 | $8.29M derived: sum of 2 quarters · filed 2015-11-06 | $12.65M 10-Q · filed 2015-11-06 | $17.19M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $4.16M 10-Q · filed 2014-08-01 | $8.53M 10-Q · filed 2015-08-06 | $13.07M derived: sum of 3 quarters · filed 2016-02-29 | $17.63M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $4.36M 10-Q · filed 2015-05-01 | $8.90M derived: sum of 2 quarters · filed 2016-02-29 | $13.47M derived: sum of 3 quarters · filed 2016-02-29 | $17.82M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $9.11M derived: sum of 2 quarters · filed 2016-02-29 | $13.46M derived: sum of 3 quarters · filed 2016-02-29 | $17.71M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $4.56M 10-Q · filed 2014-11-07 | $8.92M derived: sum of 2 quarters · filed 2014-11-07 | $13.16M 10-Q · filed 2014-11-07 | $17.35M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | $4.36M 10-Q · filed 2014-08-01 | $8.60M 10-Q · filed 2014-08-01 | $12.79M derived: sum of 3 quarters · filed 2015-02-26 | $16.77M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | $4.25M 10-Q · filed 2013-05-09 | $8.43M derived: sum of 2 quarters · filed 2015-02-26 | $12.41M derived: sum of 3 quarters · filed 2015-02-26 | $16.21M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2012-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $8.16M derived: sum of 2 quarters · filed 2015-02-26 | $11.96M derived: sum of 3 quarters · filed 2015-02-26 | $16.20M 10-K · filed 2015-02-26 | |
| 2012-09-30 | $3.98M 10-Q · filed 2012-11-09 | $7.78M derived: sum of 2 quarters · filed 2013-08-09 | $12.02M 10-Q · filed 2012-11-09 | $16.40M derived: sum of 4 quarters · filed 2013-08-09 | |
| 2012-06-30 | $3.80M 10-Q · filed 2013-08-09 | $8.04M 10-Q · filed 2013-08-09 | $12.42M derived: sum of 3 quarters · filed 2013-08-09 | $17.24M derived: sum of 4 quarters · filed 2013-08-09 | |
| 2012-03-31 | $4.23M 10-Q · filed 2013-05-09 | $8.62M derived: sum of 2 quarters · filed 2013-05-09 | $13.44M derived: sum of 3 quarters · filed 2013-05-09 | $18.32M derived: sum of 4 quarters · filed 2013-05-09 | |
| 2011-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $9.20M derived: sum of 2 quarters · filed 2013-03-01 | $14.08M derived: sum of 3 quarters · filed 2013-03-01 | $18.89M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $4.82M 10-Q · filed 2012-11-09 | $9.70M derived: sum of 2 quarters · filed 2012-11-09 | $14.50M 10-Q · filed 2012-11-09 | $19.18M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | $4.88M 10-Q · filed 2012-08-09 | $9.68M 10-Q · filed 2012-08-09 | $14.37M derived: sum of 3 quarters · filed 2013-03-01 | $18.98M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | $4.80M 10-Q · filed 2012-05-04 | $9.48M derived: sum of 2 quarters · filed 2013-03-01 | $14.10M derived: sum of 3 quarters · filed 2013-03-01 | $18.46M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2010-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $9.29M derived: sum of 2 quarters · filed 2013-03-01 | $13.65M derived: sum of 3 quarters · filed 2013-03-01 | $17.40M 10-K · filed 2013-03-01 | |
| 2010-09-30 | $4.61M 10-Q · filed 2011-11-04 | $8.97M derived: sum of 2 quarters · filed 2011-11-04 | $12.72M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $4.36M 10-Q · filed 2011-08-05 | $8.11M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $10.33M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |